Introduction
Medicaid is the second-largest government healthcare program, covering approximately 90 million Americans (roughly one in four). It is also the lowest-paying major payer, reimbursing providers at rates that are typically 60-80% of Medicare rates, which are themselves below commercial rates. For healthcare bankers, Medicaid exposure is a valuation depressant: companies with heavy Medicaid payer mix trade at lower multiples because of thinner margins, higher political risk, and slower reimbursement cycles.
How Medicaid Differs from Medicare
Unlike Medicare (a purely federal program), Medicaid is a joint federal-state partnership where the federal government sets broad requirements but each state designs and administers its own program. This creates substantial variation:
- Federal Medical Assistance Percentage (FMAP)
The formula that determines what percentage of each state's Medicaid spending the federal government reimburses. The FMAP ranges from 50% (the floor, applied to wealthier states like New York and California) to approximately 77% (for lower-income states like Mississippi). The ACA Medicaid expansion population receives a 90% federal match. FMAP variation means that Medicaid budget pressures affect states differently, with lower-income states receiving more federal support but often offering fewer benefits and lower provider rates.
| Dimension | Medicare | Medicaid |
|---|---|---|
| Administration | Federal (CMS) | State-by-state |
| Eligibility | Age 65+, disabled, ESRD | Income-based (varies by state) |
| Covered lives | ~67 million | ~90 million |
| Reimbursement | Nationally standardized (with geographic adjustments) | State-determined (wide variation) |
| Provider rates | Below commercial, above Medicaid | Lowest of any major payer |
| Managed care penetration | ~50% (Medicare Advantage) | ~80% (Medicaid managed care) |
The state-level variation is substantial. A physician in Texas might receive $40 for an office visit from Texas Medicaid, while the same visit in New York might reimburse at $55, and in California at $35. This geographic variation means that the financial impact of Medicaid exposure depends heavily on the state.
Medicaid Managed Care: The Dominant Delivery Model
Over 80% of Medicaid beneficiaries are now enrolled in managed care plans, where states contract with private insurers to manage benefits for a fixed per-member-per-month (PMPM) payment. The major Medicaid managed care organizations include:
- Centene (the largest Medicaid MCO by enrollment)
- Molina Healthcare
- UnitedHealth Group (through UnitedHealthcare Community & State)
- Elevance Health (through its Medicaid subsidiaries)
Why Medicaid Exposure Depresses Valuations
For healthcare services providers, heavy Medicaid payer mix creates multiple valuation headwinds:
Lower margins. The simple math: if Medicaid pays 60-80% of what Medicare pays, and Medicare already pays below commercial rates, Medicaid revenue generates the thinnest margins of any payer. A healthcare services company with 50% Medicaid payer mix will have structurally lower EBITDA margins than a comparable company with 50% commercial payer mix.
Political vulnerability. Medicaid budgets are subject to state political dynamics. During fiscal downturns, states face pressure to cut Medicaid provider rates, freeze eligibility, or reduce covered benefits. Unlike Medicare (which is federally administered with more predictable rate-setting), Medicaid rates can change quickly with state budget decisions.
Collections and cash flow. Medicaid reimbursement cycles are often slower than commercial or Medicare payments, and administrative denials can be more frequent. This creates working capital drag and higher accounts receivable days.
The economic differences between Medicaid, Medicare, and commercial insurance converge in the concept of payer mix, which is one of the most important valuation drivers in healthcare services.
Free Interview PDF Guide